XML 20 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities:    
Net income (loss) $ 461,193 $ (130,751)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 3,431 2,691
Reduction in carrying amount of right-of-use assets 2,124 1,994
Credit losses and sales allowances 21 272
Deferred taxes (460,061) (57,445)
Release of liabilities for unrecognized tax benefits (102) 0
Share-based compensation expense 17,555 14,394
Digital asset impairment losses 18,911 170,091
Amortization of issuance costs on long-term debt 2,210 2,129
Gain on debt extinguishment (44,686) 0
Changes in operating assets and liabilities:    
Accounts receivable 10,241 8,183
Prepaid expenses and other current assets 423 (2,838)
Deposits and other assets (6) (5,801)
Accounts payable and accrued expenses 4,230 (2,041)
Accrued compensation and employee benefits (16,327) (12,735)
Accrued interest 7,539 9,051
Deferred revenue and advance payments 33,352 48,895
Operating lease liabilities (2,594) (2,382)
Other long-term liabilities (57) (25)
Net cash provided by operating activities 37,397 43,682
Investing activities:    
Purchases of digital assets (179,275) (215,500)
Purchases of property and equipment (499) (641)
Net cash used in investing activities (179,774) (216,141)
Financing activities:    
Proceeds from secured term loan, net of lender fees 0 204,693
Repayments of secured term loan (159,900) 0
Repayments of other long-term secured debt (128) 0
Proceeds from sale of common stock under public offerings 341,062 0
Issuance costs paid related to sale of common stock under public offerings (2,045) 0
Proceeds from exercise of stock options 6,750 288
Payment of withholding tax on vesting of restricted stock units (497) (495)
Net cash provided by financing activities 187,622 207,291
Effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash 351 (324)
Net (decrease) increase in cash, cash equivalents, and restricted cash 45,596 34,508
Cash, cash equivalents, and restricted cash, beginning of period 50,868 64,434
Cash, cash equivalents, and restricted cash, end of period 96,464 98,942
Employee Stock Purchase Plan    
Financing activities:    
Proceeds from sales under employee stock purchase plan $ 2,380 $ 2,805